New Cancer Treatment Brings Hope in 2001

unseasoned Cancer Treatment Brings Hope in 2001 by liza Jane Maltin On May 10 2001, FDA approved a new dose known as Gleevec ( pull inerly St1- 571) for successfully treating cancer of the white parentage cells known as continuing myelogenous leukemia (CML) and a rare form of cancer that affects the stomach and intestines called gastrointestinal stromal tumors (GIST). According to Michael Heinrich, MD, an associate professor of medicine at surgery Health Sciences University in Portland and a division of the team that highly-developed Gleevec, conventional leukemia therapy like chemotherapy and radiation, kill perverted marrow cells, unless to a fault destroy healthy ones and thereof extremely unvoiced to tolerate. Gleevec, on the other hand, selectively tar conk outs an maverick cancer - causing protein called BCR-ABL, which causes the cancerous white blood cells to see down out of control. Research is underway to test Gleevecs strong point against some kinds of brai n, lung, prostate, colorectal and pancreatic cancers.

Heinrich is optimistic round the front results and predicts fundamental changes non only in how we treat cancer, but also in the very way we think and talk about it. Works Citied Maltin Jane Liza, New Cancer Treatment Brings Hope in 2001. WebMD Health, Dec. 26, 2001 If you want to get a full essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper